Delivery Order SPE2DB24D2100-SPE2DB25FBDRH

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a medical product, with a ceiling value of $26,931.21 and a performance period ending on May 13, 2025. The contract is a firm fixed-price type and is not set aside for any specific socioeconomic program. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $22,989.42 and a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,797.70, is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The delivery order contract has a firm fixed price pricing type and an ultimate completion date of May 31, 2024. The contract was not set aside for any specific business size or socioeconomic category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,555.44, is for the supply of RENFLEXIS 100 MG VIALS, a medical product. The contract has a firm fixed price pricing type and runs through April 2, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a medical supply, with a ceiling value of $52,570.69. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,231.72, is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of December 20, 2024. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product, with a firm fixed price ceiling value of $17,540.28 and a period of performance through May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. The contract is a firm fixed-price delivery order with a ceiling value of $5,264.81 and a completion date of May 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. The contract has a ceiling value of $16,869.61 and a performance period that ends on September 4, 2024. It is a firm-fixed-price contract, which means the price will not change regardless of the contractor's costs. The contract is not set-aside for any specific business category. AmerisourceBergen holds several...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,909.12 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDRH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price of $5,492.24 and a performance period ending on April 21, 2025. This contract is not set aside for any specific business category.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 10:00 AM